We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Ireland Launches Human Genomics Program

By Biotechdaily staff writers
Posted on 21 Aug 2002
A Program for Human Genomics, aimed at learning more about the genetic causes of disease and how to improve treatments, has been launched in Ireland. More...
The initiative is led by the Royal College of Surgeons in Ireland (RCSI, Dublin), in collaboration with Trinity College and University College (also in Dublin).

The new program will join two existing centers of research in Ireland, the Dublin Molecular Medicine Center and the Biopharmaceutical Science Network. Both link basic laboratory research with actual patient care in a clinical context. The new program has three key operational elements that reflect the research to be pursued. The first is to search for candidate genes thought to play a role in disease. The second is to confirm their involvement in the disease process. The third is to understand the proteins produced by these genes so they can be targeted with new therapies.

A key resource will be the creation of a "biobank,” a genetic database of information that will assist the research. The goal is to assemble a biobank of 50,000 individuals within five years. The RCSI already has a bank of 5,000 samples, and future donations will be accepted on an anonymous basis. Donations will be taken from patients with a well-defined clinical condition for which a detailed medical history is available, such as asthma, diabetes, or high blood pressure.

Research teams will study these genomic collections for disease-related genes. The program will also have genetic resource units at three hospitals and links with biobanks at University College and Sligo Hospital.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Pipette Calibration System
Artel PCS®
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.